Vanda Pharmaceuticals (VNDA) EBT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.42% |
| Dec 31, 2025 | -33.86% |
| Sep 30, 2025 | 18.62% |
| Jun 30, 2025 | 6.64% |
| Mar 31, 2025 | -475.16% |
| Dec 31, 2024 | -4.05% |
| Sep 30, 2024 | -13.20% |
| Jun 30, 2024 | -18.27% |
| Mar 31, 2024 | -180.79% |
| Dec 31, 2023 | -1,284.17% |
| Sep 30, 2023 | -104.63% |
| Jun 30, 2023 | -53.11% |
| Mar 31, 2023 | -42.49% |
| Dec 31, 2022 | 76.03% |
| Sep 30, 2022 | 44.09% |
| Jun 30, 2022 | 150.11% |
| Mar 31, 2022 | -187.85% |
| Dec 31, 2021 | -19.70% |
| Sep 30, 2021 | -14.93% |
| Jun 30, 2021 | 20.87% |
| Mar 31, 2021 | -4.54% |
| Dec 31, 2020 | 30.03% |
| Sep 30, 2020 | -24.24% |
| Jun 30, 2020 | 793.55% |
| Mar 31, 2020 | -78.64% |
| Dec 31, 2019 | -52.67% |
| Sep 30, 2019 | 6.34% |
| Jun 30, 2019 | 2,017.61% |
| Mar 31, 2019 | -105.83% |
| Dec 31, 2018 | 42.06% |
| Sep 30, 2018 | 54.50% |
| Jun 30, 2018 | 53.43% |
| Mar 31, 2018 | 274.99% |
| Dec 31, 2017 | 61.32% |
| Sep 30, 2017 | -196.46% |
| Jun 30, 2017 | 79.98% |
| Mar 31, 2017 | -1,425.20% |
| Dec 31, 2016 | -16.28% |
| Sep 30, 2016 | 90.69% |
| Jun 30, 2016 | 62.63% |
| Mar 31, 2016 | 17.02% |
| Dec 31, 2015 | -56.09% |
| Sep 30, 2015 | -74.81% |
| Jun 30, 2015 | 46.97% |
| Mar 31, 2015 | -114.77% |
| Dec 31, 2014 | 4,913.05% |
| Sep 30, 2014 | 93.29% |
| Jun 30, 2014 | 18.69% |
| Mar 31, 2014 | -248.07% |
| Dec 31, 2013 | -41.69% |
| Sep 30, 2013 | -59.03% |
| Jun 30, 2013 | 25.14% |
| Mar 31, 2013 | -122.22% |
| Dec 31, 2012 | 481.94% |
| Sep 30, 2012 | 33.48% |
| Jun 30, 2012 | -0.57% |
| Mar 31, 2012 | -37.06% |
| Dec 31, 2011 | -82.27% |
| Sep 30, 2011 | -128.95% |
| Jun 30, 2011 | -1,080.28% |
| Mar 31, 2011 | -84.78% |
| Dec 31, 2010 | 3.78% |
| Sep 30, 2010 | -27.67% |